Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer von Stathopoulos, G. P., Rigatos, S. K., Dimopoulos, M. A., Giannakakis, T., Foutzilas, G., Kouroussis, C., Janninis, D., Aravantinos, G., Androulakis, N., Agelaki, S., Stathopoulos, J. G., Georgoulias, V.

Volltext

PCN47 ECONOMIC EVALUATION IN THE POSTOPERATIVE MANAGEMENT OF COLORECTAL CANCER PATIENTS IN GREECE von Maniadakis, N, Fragoulakis, V, Pectasides, D, Foutzilas, G

Volltext

Multicenter phase II trial of first-line irinotecan (CPT-11) and gemcitabine (GMB) in patients with unresectable pancreatic cancer von Stathopoulos, G., Rigatos, S., Androulakis, N., Souglakos, J., Kouroussis, Ch, Dimopoulos, A.M., Aravantinos, G., Giannakakis, Th, Foutzilas, G., Stathopoulos, J., Georgoulias, V.

Volltext

1078 Randomized comparison of Etoposide-Cisplatin vs Etoposide-Carboplatin and irradiation in small cell lung cancer (SCLC): Evaluation of long term survival von Samantas, E., Milonakis, M., Klouvas, G., Panoussaki, A., Agelidou, M., Palamidas, F., Boleli, E., Kosmas, E., Papadakis, E., Kiamouris, N., Vardoulakis, T., Kosmidis, P., Pavlidis, N., Foutzilas, G., Skarios, D.V.

Volltext